Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Change in Inventory (2016 - 2025)

Angiodynamics (ANGO) has disclosed Change in Inventory for 16 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory rose 162.48% year-over-year to $3.3 million, compared with a TTM value of -$483000.0 through Nov 2025, down 108.23%, and an annual FY2025 reading of $1.3 million, down 85.69% over the prior year.
  • Change in Inventory was $3.3 million for Q4 2025 at Angiodynamics, up from $192000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.2 million in Q3 2022 and bottomed at -$4.1 million in Q2 2023.
  • Average Change in Inventory over 5 years is $1.2 million, with a median of $546500.0 recorded in 2021.
  • The sharpest move saw Change in Inventory surged 905.71% in 2022, then crashed 577.3% in 2024.
  • Year by year, Change in Inventory stood at -$1.1 million in 2021, then surged by 587.2% to $5.6 million in 2022, then fell by 23.65% to $4.3 million in 2023, then tumbled by 70.73% to $1.2 million in 2024, then soared by 162.48% to $3.3 million in 2025.
  • Business Quant data shows Change in Inventory for ANGO at $3.3 million in Q4 2025, $192000.0 in Q3 2025, and -$1.1 million in Q2 2025.